To further investigate the impact of FXR activation on CSCs, we sorted CD133+ and CD133− cells from the HepG2, Huh7, and PLC/PRF/5 HCC cell lines using flow cytometry. The gene discussed is PROM1; the disease is hepatocellular carcinoma.